???global.info.a_carregar???
Identificação

Identificação pessoal

Nome completo
Ana Isabel Figueira Verdelho

Nomes de citação

  • Verdelho, Ana

Identificadores de autor

Ciência ID
FC14-938F-EBBD
ORCID iD
0000-0003-4945-4946
Formação
Grau Classificação
2008/01/01 - 2013/01/01
Concluído
Medicina (Doutoramento)
Especialização em Neurologia
Universidade de Lisboa Faculdade de Medicina, Portugal
"Clinical implications of cerebral age-related white matter changes" (TESE/DISSERTAÇÃO)
Aprovado com Louvor e Distinção, por unanimidade
1987/01/09 - 1993/07/07
Concluído
Medicina (Licenciatura)
Universidade de Lisboa Faculdade de Medicina, Portugal
16.1
Percurso profissional

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento
Empregador
2016 - Atual Professor Auxiliar Convidado (Docente Universitário) Universidade de Lisboa, Portugal
Universidade de Lisboa Faculdade de Medicina, Portugal
2013 - 2016 Professor Auxiliar Convidado (Docente Universitário) Universidade de Lisboa Faculdade de Medicina, Portugal
Projetos

Projeto

Designação Financiadores
2016/07/01 - 2020/05/31 Impacto da actividade física no defeito cognitivo vascular
FCT-PTDC/DTP-ES/3706/2014
Investigador responsável
Universidade de Lisboa Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Concluído
2000 - 2006 Estudo LADIS - The Leukoaraiosis And DISability (LADIS) study. Estudo colaborativo europeu.
QLK6-2000-00446
Investigador
Universidade de Lisboa Faculdade de Medicina, Portugal
Concluído
Produções

Publicações

Artigo em revista
  1. Linnemann C; Wilke C; Mengel D; Zetterberg H; Heller C; Kuhle J; Bouzigues A; et al. "NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study.". Journal of neurology, neurosurgery, and psychiatry (2024): http://europepmc.org/abstract/med/38253362.
    10.1136/jnnp-2023-332464
  2. Benussi A; Premi E; Grassi M; Alberici A; Cantoni V; Gazzina S; Archetti S; et al. "Diagnostic accuracy of research criteria for prodromal frontotemporal dementia.". Alzheimer's research & therapy (2024): http://europepmc.org/abstract/med/38216961.
    10.1186/s13195-024-01383-1
  3. Ferreira-Brito F; Alves S; Guerreiro T; Santos O; Caneiras C; Carriço L; Verdelho A. "Digital health and patient adherence: A qualitative study in older adults.". Digital health (2024): http://europepmc.org/abstract/med/38222080.
    10.1177/20552076231223805
  4. Ullgren A; Öijerstedt L; Olofsson J; Bergström S; Remnestål J; van Swieten JC; Jiskoot LC; et al. "Altered plasma protein profiles in genetic FTD - a GENFI study.". Molecular neurodegeneration (2023): http://europepmc.org/abstract/med/37968725.
    10.1186/s13024-023-00677-6
  5. Samra K; MacDougall AM; Bouzigues A; Bocchetta M; Cash DM; Greaves CV; Convery RS; et al. "Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort.". Journal of the neurological sciences (2023): http://europepmc.org/abstract/med/37348248.
    10.1016/j.jns.2023.120711
  6. Vítor J; Melita C; Rodrigues M; de Sousa DA; Costa J; Ferro JM; Verdelho A. "Physical activity in vascular cognitive impairment: Systematic review with meta-analysis.". Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association (2023): http://europepmc.org/abstract/med/37156089.
    10.1016/j.jstrokecerebrovasdis.2023.107133
  7. Finger E; Malik R; Bocchetta M; Coleman K; Graff C; Borroni B; Masellis M; et al. "Neurodevelopmental effects of genetic frontotemporal dementia in young adult mutation carriers.". Brain : a journal of neurology (2023): http://europepmc.org/abstract/med/36458975.
    10.1093/brain/awac446
  8. Bocchetta M; Todd EG; Bouzigues A; Cash DM; Nicholas JM; Convery RS; Russell LL; et al. "Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort.". Brain communications (2023): http://europepmc.org/abstract/med/36970046.
    10.1093/braincomms/fcad061
  9. Bussy A; Levy JP; Best T; Patel R; Cupo L; Van Langenhove T; Nielsen JE; et al. "Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia.". Human brain mapping (2023): http://europepmc.org/abstract/med/36895129.
    10.1002/hbm.26220
  10. Premi E; Pengo M; Mattioli I; Cantoni V; Dukart J; Gasparotti R; Buratti E; et al. "Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study.". Neurobiology of disease (2023): http://europepmc.org/abstract/med/36898614.
    10.1016/j.nbd.2023.106068
  11. Silva RPE; Sousa DA; Lopes FA; Silva-Ramos M; Verdelho A. "Age-related white matter hyperintensities and overactive bladder: A systematic review.". Neurourology and urodynamics (2023): http://europepmc.org/abstract/med/36971037.
    10.1002/nau.25174
  12. Samra K; MacDougall AM; Bouzigues A; Bocchetta M; Cash DM; Greaves CV; Convery RS; et al. "Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia.". Brain communications (2023): http://europepmc.org/abstract/med/36938528.
    10.1093/braincomms/fcad036
  13. Samra K; Macdougall A; Peakman G; Bouzigues A; Bocchetta M; Cash DM; Greaves CV; et al. "Neuropsychiatric symptoms in genetic frontotemporal dementia: developing a new module for Clinical Rating Scales.". Journal of neurology, neurosurgery, and psychiatry (2023): http://europepmc.org/abstract/med/36627201.
    10.1136/jnnp-2022-330152
  14. Shafiei G; Bazinet V; Dadar M; Manera AL; Collins DL; Dagher A; Borroni B; et al. "Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia.". Brain : a journal of neurology (2023): http://europepmc.org/abstract/med/35188955.
    10.1093/brain/awac069
  15. Samra K; MacDougall AM; Bouzigues A; Bocchetta M; Cash DM; Greaves CV; Convery RS; et al. "Language impairment in the genetic forms of behavioural variant frontotemporal dementia.". Journal of neurology (2022): http://europepmc.org/abstract/med/36538154.
    10.1007/s00415-022-11512-1
  16. Samra K; MacDougall AM; Peakman G; Bouzigues A; Bocchetta M; Cash DM; Greaves CV; et al. "Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales.". Journal of neurology (2022): http://europepmc.org/abstract/med/36385202.
    10.1007/s00415-022-11442-y
  17. Whiteside DJ; Malpetti M; Jones PS; Ghosh BCP; Coyle-Gilchrist I; van Swieten JC; Seelaar H; et al. "Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia.". Alzheimer's & dementia : the journal of the Alzheimer's Association (2022): http://europepmc.org/abstract/med/36377606.
    10.1002/alz.12824
  18. Markus HS; van Der Flier WM; Smith EE; Bath P; Biessels GJ; Briceno E; Brodtman A; et al. "Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE): A Review.". JAMA neurology (2022): http://europepmc.org/abstract/med/35969390.
    10.1001/jamaneurol.2022.2262
  19. Pérez-Millan A; Borrego-Écija S; van Swieten JC; Jiskoot L; Moreno F; Laforce R; Graff C; et al. "Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study.". Journal of neurology (2022): http://europepmc.org/abstract/med/36443488.
    10.1007/s00415-022-11435-x
  20. Woollacott IOC; Swift IJ; Sogorb-Esteve A; Heller C; Knowles K; Bouzigues A; Russell LL; et al. "CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia.". Annals of clinical and translational neurology (2022): http://europepmc.org/abstract/med/36245297.
    10.1002/acn3.51672
  21. Staffaroni AM; Quintana M; Wendelberger B; Heuer HW; Russell LL; Cobigo Y; Wolf A; et al. "Temporal order of clinical and biomarker changes in familial frontotemporal dementia.". Nature medicine (2022): http://europepmc.org/abstract/med/36138153.
    10.1038/s41591-022-01942-9
  22. van der Ende EL; Heller C; Sogorb-Esteve A; Swift IJ; McFall D; Peakman G; Bouzigues A; et al. "Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study.". Journal of neuroinflammation (2022): http://europepmc.org/abstract/med/36064709.
    10.1186/s12974-022-02573-0
  23. Premi E; Giunta M; Iraji A; Rachakonda S; Calhoun V; Gazzina S; Benussi A; et al. "Corrigendum to "Dissemination in time and space in presymptomatic granulin mutation carriers: A spatial chronnectome study" [Neurobiology of Aging Volume 108, December 2021, Pages 155-167].". Neurobiology of aging (2022): http://europepmc.org/abstract/med/36064515.
    10.1016/j.neurobiolaging.2022.08.005
  24. Sogorb-Esteve A; Nilsson J; Swift IJ; Heller C; Bocchetta M; Russell LL; Peakman G; et al. "Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia.". Alzheimer's research & therapy (2022): http://europepmc.org/abstract/med/36045450.
    10.1186/s13195-022-01042-3
  25. Bruffaerts R; Gors D; Bárcenas Gallardo A; Vandenbulcke M; Van Damme P; Suetens P; van Swieten JC; et al. "Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72.". Brain communications (2022): http://europepmc.org/abstract/med/35898720.
    10.1093/braincomms/fcac182
  26. van der Ende EL; Bron EE; Poos JM; Jiskoot LC; Panman JL; Papma JM; Meeter LH; et al. "A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia.". Brain : a journal of neurology (2022): http://europepmc.org/abstract/med/34633446.
    10.1093/brain/awab382
  27. Poos JM; MacDougall A; van den Berg E; Jiskoot LC; Papma JM; van der Ende EL; Seelaar H; et al. "Longitudinal Cognitive Changes in Genetic Frontotemporal Dementia Within the GENFI Cohort.". Neurology (2022): http://europepmc.org/abstract/med/35483895.
    10.1212/wnl.0000000000200384
  28. Wilson KM; Katona E; Glaria I; Carcolé M; Swift IJ; Sogorb-Esteve A; Heller C; et al. "Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis.". Journal of neurology, neurosurgery, and psychiatry (2022): http://europepmc.org/abstract/med/35379698.
    10.1136/jnnp-2021-328710
  29. Bouzigues A; Russell LL; Peakman G; Bocchetta M; Greaves CV; Convery RS; Todd E; et al. "Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations.". Journal of neurology (2022): http://europepmc.org/abstract/med/35348856.
    10.1007/s00415-022-11068-0
  30. Gazzina S; Grassi M; Premi E; Alberici A; Benussi A; Archetti S; Gasparotti R; et al. "Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia.". Neurobiology of aging (2022): http://europepmc.org/abstract/med/35339292.
    10.1016/j.neurobiolaging.2022.02.009
  31. Foster PH; Russell LL; Peakman G; Convery RS; Bouzigues A; Greaves CV; Bocchetta M; et al. "Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort.". Cortex; a journal devoted to the study of the nervous system and behavior (2022): http://europepmc.org/abstract/med/35325762.
    10.1016/j.cortex.2022.01.012
  32. McCarthy J; Borroni B; Sanchez-Valle R; Moreno F; Laforce R; Graff C; Synofzik M; et al. "Data-driven staging of genetic frontotemporal dementia using multi-modal MRI.". Human brain mapping (2022): http://europepmc.org/abstract/med/35118777.
    10.1002/hbm.25727
  33. Premi E; Costa T; Gazzina S; Benussi A; Cauda F; Gasparotti R; Archetti S; et al. "An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers.". Journal of Alzheimer's disease : JAD (2022): http://europepmc.org/abstract/med/35068455.
    10.3233/jad-215447
  34. Poos JM; Moore KM; Nicholas J; Russell LL; Peakman G; Convery RS; Jiskoot LC; et al. "Cognitive composites for genetic frontotemporal dementia: GENFI-Cog.". Alzheimer's research & therapy (2022): http://europepmc.org/abstract/med/35045872.
    10.1186/s13195-022-00958-0
  35. Verdelho A; Correia M; Ferro JM; Madureira S; Vilela P; Rodrigues M; Borges M; et al. "Physical Activity Self-Report Is Not Reliable Among Subjects with Mild Vascular Cognitive Impairment: The AFIVASC Study.". Journal of Alzheimer's disease : JAD (2022): http://europepmc.org/abstract/med/35275531.
    10.3233/jad-215381
  36. Benussi A; Alberici A; Samra K; Russell LL; Greaves CV; Bocchetta M; Ducharme S; et al. "Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia.". Alzheimer's & dementia : the journal of the Alzheimer's Association (2021): http://europepmc.org/abstract/med/34874596.
    10.1002/alz.12485
  37. Wilke C; Reich S; van Swieten JC; Borroni B; Sanchez-Valle R; Moreno F; Laforce R; et al. "Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study.". Annals of neurology (2021): http://europepmc.org/abstract/med/34743360.
    10.1002/ana.26265
  38. Bergström S; Öijerstedt L; Remnestål J; Olofsson J; Ullgren A; Seelaar H; van Swieten JC; et al. "A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study.". Molecular neurodegeneration (2021): http://europepmc.org/abstract/med/34838088.
    10.1186/s13024-021-00499-4
  39. Quinn TJ; Richard E; Teuschl Y; Gattringer T; Hafdi M; O'Brien JT; Merriman N; et al. "European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment.". European stroke journal (2021): http://europepmc.org/abstract/med/34746430.
    10.1177/23969873211042192
  40. Quinn TJ; Richard E; Teuschl Y; Gattringer T; Hafdi M; O'Brien JT; Merriman N; et al. "European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment.". European journal of neurology (2021): http://europepmc.org/abstract/med/34476868.
    10.1111/ene.15068
  41. Öijerstedt L; Andersson C; Jelic V; van Swieten JC; Jiskoot LC; Seelaar H; Borroni B; et al. "Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study.". Journal of neurology, neurosurgery, and psychiatry (2021): http://europepmc.org/abstract/med/34408008.
    10.1136/jnnp-2021-327005
  42. Peakman G; Russell LL; Convery RS; Nicholas JM; Van Swieten JC; Jiskoot LC; Moreno F; et al. "Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort.". Journal of neurology, neurosurgery, and psychiatry (2021): http://europepmc.org/abstract/med/34353857.
    10.1136/jnnp-2021-326868
  43. Franklin HD; Russell LL; Peakman G; Greaves CV; Bocchetta M; Nicholas J; Poos J; et al. "The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort.". Alzheimer's research & therapy (2021): http://europepmc.org/abstract/med/34253227.
    10.1186/s13195-021-00865-w
  44. Ana Verdelho; Geert Jan Biessels; Hugues Chabriat; Andreas Charidimou; Marco Duering; Olivier Godefroy; Leonardo Pantoni; Aleksandra Pavlovic; Joanna Wardlaw. "Cerebrovascular disease in patients with cognitive impairment: A white paper from the ESO dementia committee – A practical point of view with suggestions for the management of cerebrovascular diseases in memory clinics". European Stroke Journal 6 2 (2021): 111-119. https://doi.org/10.1177/2396987321994294.
    10.1177/2396987321994294
  45. Young AL; Bocchetta M; Russell LL; Convery RS; Peakman G; Todd E; Cash DM; et al. "Characterizing the Clinical Features and Atrophy Patterns of MAPT-Related Frontotemporal Dementia With Disease Progression Modeling.". Neurology (2021): http://europepmc.org/abstract/med/34158384.
    10.1212/wnl.0000000000012410
  46. Poos JM; Russell LL; Peakman G; Bocchetta M; Greaves CV; Jiskoot LC; van der Ende EL; et al. "Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study.". Alzheimer's & dementia (Amsterdam, Netherlands) (2021): http://europepmc.org/abstract/med/34027016.
    10.1002/dad2.12185
  47. Ana Verdelho; Joanna Wardlaw; Aleksandra Pavlovic; Leonardo Pantoni; Olivier Godefroy; Marco Duering; Andreas Charidimou; et al. "Cognitive impairment in patients with cerebrovascular disease: A white paper from the links between stroke ESO Dementia Committee". European Stroke Journal 6 1 (2021): 5-17. https://doi.org/10.1177/23969873211000258.
    10.1177/23969873211000258
  48. Bocchetta M; Todd EG; Peakman G; Cash DM; Convery RS; Russell LL; Thomas DL; et al. "Differential early subcortical involvement in genetic FTD within the GENFI cohort.". NeuroImage. Clinical (2021): http://europepmc.org/abstract/med/33895632.
    10.1016/j.nicl.2021.102646
  49. Manera AL; Dadar M; Van Swieten JC; Borroni B; Sanchez-Valle R; Moreno F; Laforce R; et al. "MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia.". Journal of neurology, neurosurgery, and psychiatry (2021): http://europepmc.org/abstract/med/33722819.
    10.1136/jnnp-2020-324106
  50. Panman JL; Venkatraghavan V; van der Ende EL; Steketee RME; Jiskoot LC; Poos JM; Dopper EGP; et al. "Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia.". Journal of neurology, neurosurgery, and psychiatry (2021): http://europepmc.org/abstract/med/33452053.
    10.1136/jnnp-2020-323541
  51. Benussi A; Premi E; Gazzina S; Brattini C; Bonomi E; Alberici A; Jiskoot L; et al. "Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia.". JAMA network open (2021): http://europepmc.org/abstract/med/33404617.
    10.1001/jamanetworkopen.2020.30194
  52. Musaeus CS; Nilsson C; Cooper C; Kramberger MG; Verdelho A; Stefanova E; Religa D; Waldemar G; Frederiksen KS. "Pharmacological Medical Treatment of Epilepsy in Patients with Dementia: A Systematic Review.". Current Alzheimer research (2021): http://europepmc.org/abstract/med/34825872.
    10.2174/1567205018666211126121529
  53. Ferreira-Brito F; Ribeiro F; Aguiar de Sousa D; Costa J; Caneiras C; Carriço L; Verdelho A. "Are Video Games Effective to Promote Cognition and Everyday Functional Capacity in Mild Cognitive Impairment/Dementia Patients? A Meta-Analysis of Randomized Controlled Trials.". Journal of Alzheimer's disease : JAD (2021): http://europepmc.org/abstract/med/34542073.
    10.3233/jad-210545
  54. Borrego-Écija S; Sala-Llonch R; van Swieten J; Borroni B; Moreno F; Masellis M; Tartaglia C; et al. "Disease-related cortical thinning in presymptomatic granulin mutation carriers.". NeuroImage. Clinical (2020): http://europepmc.org/abstract/med/33418170.
    10.1016/j.nicl.2020.102540
  55. Malpetti M; Jones PS; Tsvetanov KA; Rittman T; van Swieten JC; Borroni B; Sanchez-Valle R; et al. "Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes.". Alzheimer's & dementia : the journal of the Alzheimer's Association (2020): http://europepmc.org/abstract/med/33316852.
    10.1002/alz.12252
  56. Tsvetanov KA; Gazzina S; Jones PS; van Swieten J; Borroni B; Sanchez-Valle R; Moreno F; et al. "Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia.". Alzheimer's & dementia : the journal of the Alzheimer's Association (2020): http://europepmc.org/abstract/med/33215845.
    10.1002/alz.12209
  57. Russell LL; Greaves CV; Bocchetta M; Nicholas J; Convery RS; Moore K; Cash DM; et al. "Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort.". Cortex; a journal devoted to the study of the nervous system and behavior (2020): http://europepmc.org/abstract/med/33221702.
    10.1016/j.cortex.2020.08.023
  58. Moreira I; Ferreira A; Verdelho A; Pereira B; Fitas D; Coelho F; Faria F; et al. "A prodigious intracerebral lesion infiltrating the adjacent skull.". Current problems in cancer (2020): http://europepmc.org/abstract/med/32888699.
    10.1016/j.currproblcancer.2020.100642
  59. Tavares TP; Mitchell DGV; Coleman KK; Coleman BL; Shoesmith CL; Butler CR; Santana I; et al. "Early symptoms in symptomatic and preclinical genetic frontotemporal lobar degeneration.". Journal of neurology, neurosurgery, and psychiatry (2020): http://europepmc.org/abstract/med/32769115.
    10.1136/jnnp-2020-322987
  60. Convery RS; Bocchetta M; Greaves CV; Moore KM; Cash DM; Van Swieten J; Moreno F; et al. "Abnormal pain perception is associated with thalamo-cortico-striatal atrophy in C9orf72 expansion carriers in the GENFI cohort.". Journal of neurology, neurosurgery, and psychiatry (2020): http://europepmc.org/abstract/med/32759310.
    10.1136/jnnp-2020-323279
  61. Altmann A; Cash DM; Bocchetta M; Heller C; Reynolds R; Moore K; Convery RS; et al. "Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia.". Brain communications (2020): http://europepmc.org/abstract/med/33210084.
    10.1093/braincomms/fcaa122
  62. Le Blanc G; Jetté Pomerleau V; McCarthy J; Borroni B; van Swieten J; Galimberti D; Sanchez-Valle R; et al. "Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers.". Annals of neurology (2020): http://europepmc.org/abstract/med/32285980.
    10.1002/ana.25748
  63. van der Ende EL; Xiao M; Xu D; Poos JM; Panman JL; Jiskoot LC; Meeter LH; et al. "Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia.". Journal of neurology, neurosurgery, and psychiatry (2020): http://europepmc.org/abstract/med/32273328.
    10.1136/jnnp-2019-322493
  64. Heller C; Foiani MS; Moore K; Convery R; Bocchetta M; Neason M; Cash DM; et al. "Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.". Journal of neurology, neurosurgery, and psychiatry (2020): http://europepmc.org/abstract/med/31937580.
    10.1136/jnnp-2019-321954
  65. Carvalho Dias, Mariana; Martins, Teresa; Basílio, Gonçalo; Lucas Neto, Lia; Caeiro, Lara; Ferro, José; Verdelho, Ana. "Headache at the chronic stage of ischemic stroke". (2020): http://hdl.handle.net/10451/45973.
    10.1111/head.13761
  66. Frederiksen, K. S.; Cooper, C.; Frisoni, G. B.; Frölich, L.; Georges, J.; Kramberger, M. G.; Nilsson, C.; et al. "A European Academy of Neurology guideline on medical management issues in dementia". (2020): http://hdl.handle.net/10451/44154.
    10.1111/ene.14412
  67. Ferreira-Brito, Filipa; Alves, Sérgio; Santos, Osvaldo; Guerreiro, Tiago; Caneiras, Catia; Carriço, Luis; Verdelho, Ana. "Photo-realistic interactive virtual environments for neurorehabilitation in mild cognitive impairment (NeuroVRehab.PT) : a participatory design and proof-of-concept study". (2020): http://hdl.handle.net/10451/45245.
    10.3390/jcm9123821
  68. Moore KM; Nicholas J; Grossman M; McMillan CT; Irwin DJ; Massimo L; Van Deerlin VM; et al. "Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study.". The Lancet. Neurology (2019): http://europepmc.org/abstract/med/31810826.
    10.1016/s1474-4422(19)30394-1
  69. van der Ende EL; Meeter LH; Poos JM; Panman JL; Jiskoot LC; Dopper EGP; Papma JM; et al. "Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study.". The Lancet. Neurology (2019): http://europepmc.org/abstract/med/31701893.
    10.1016/s1474-4422(19)30354-0
  70. Jokinen H; Koikkalainen J; Laakso HM; Melkas S; Nieminen T; Brander A; Korvenoja A; et al. "Global Burden of Small Vessel Disease-Related Brain Changes on MRI Predicts Cognitive and Functional Decline.". Stroke (2019): http://europepmc.org/abstract/med/31699021.
    10.1161/strokeaha.119.026170
  71. Sudre CH; Bocchetta M; Heller C; Convery R; Neason M; Moore KM; Cash DM; et al. "White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study.". NeuroImage. Clinical (2019): http://europepmc.org/abstract/med/31835286.
    10.1016/j.nicl.2019.102077
  72. Tavares TP; Mitchell DGV; Coleman K; Shoesmith C; Bartha R; Cash DM; Moore KM; et al. "Ventricular volume expansion in presymptomatic genetic frontotemporal dementia.". Neurology (2019): http://europepmc.org/abstract/med/31578297.
    10.1212/wnl.0000000000008386
  73. Gazzina S; Grassi M; Premi E; Cosseddu M; Alberici A; Archetti S; Gasparotti R; et al. "Education modulates brain maintenance in presymptomatic frontotemporal dementia.". Journal of neurology, neurosurgery, and psychiatry (2019): http://europepmc.org/abstract/med/31182509.
    10.1136/jnnp-2019-320439
  74. Mutsaerts HJMM; Mirza SS; Petr J; Thomas DL; Cash DM; Bocchetta M; de Vita E; et al. "Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study.". Brain : a journal of neurology (2019): http://europepmc.org/abstract/med/30847466.
    10.1093/brain/awz039
  75. Premi E; Calhoun VD; Diano M; Gazzina S; Cosseddu M; Alberici A; Archetti S; et al. "The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint.". NeuroImage (2019): http://europepmc.org/abstract/med/30716457.
    10.1016/j.neuroimage.2019.01.080
  76. Rittman T; Borchert R; Jones S; van Swieten J; Borroni B; Galimberti D; Masellis M; et al. "Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia.". Neurobiology of aging (2019): http://europepmc.org/abstract/med/30831384.
    10.1016/j.neurobiolaging.2018.12.009
  77. Brito, Filipa Ferreira; Fialho, Mónica; Virgolino, Ana; Neves, Inês; Miranda, Ana Cristina; Sousa-Santos, Nuno; Caneiras, Catia; et al. "Game-based interventions for neuropsychological assessment, training and rehabilitation : which game-elements to use? A systematic review". (2019): http://hdl.handle.net/10451/39641.
    10.1016/j.jbi.2019.103287
  78. Verdelho, Ana; Madureira, Sofia; Correia, Manuel; Ferro, José Manuel; Rodrigues, Mário; Gonçalves-Pereira, Manuel; Gonçalves, Mafalda; et al. "Impact of physical activity in vascular cognitive impairment (AFIVASC): study protocol for a randomised controlled trial". (2019): http://hdl.handle.net/10400.16/2451.
    10.1186/s13063-019-3174-1
  79. Pereira, Manuel Gonçalves; Marques, Maria J.; Balsinha, Conceição; Fernandes, Alexandra; Machado, Ana Sá; Verdelho, Ana; Barahona Corrêa, Bernardo; et al. "Necessidades de cuidados e recurso aos serviços na demência : avaliação inicial da coorte portuguesa no estudo Actifcare". Acta Médica Portuguesa 32 5 (2019): 355-355. http://hdl.handle.net/10451/39650.
    10.20344/amp.11136.
  80. Cury C; Durrleman S; Cash DM; Lorenzi M; Nicholas JM; Bocchetta M; van Swieten JC; et al. "Spatiotemporal analysis for detection of pre-symptomatic shape changes in neurodegenerative diseases: Initial application to the GENFI cohort.". NeuroImage (2018): http://europepmc.org/abstract/med/30529631.
    10.1016/j.neuroimage.2018.11.063
  81. Young AL; Marinescu RV; Oxtoby NP; Bocchetta M; Yong K; Firth NC; Cash DM; et al. "Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference.". Nature communications (2018): http://europepmc.org/abstract/med/30323170.
    10.1038/s41467-018-05892-0
  82. Jiskoot LC; Bocchetta M; Nicholas JM; Cash DM; Thomas D; Modat M; Ourselin S; et al. "Presymptomatic white matter integrity loss in familial frontotemporal dementia in the GENFI cohort: A cross-sectional diffusion tensor imaging study.". Annals of clinical and translational neurology (2018): http://europepmc.org/abstract/med/30250860.
    10.1002/acn3.601
  83. de Mendonça A; Felgueiras H; Verdelho A; Câmara S; Grilo C; Maroco J; Pereira A; Guerreiro M. "Memory complaints in amnestic Mild Cognitive Impairment: More prospective or retrospective?". International journal of geriatric psychiatry (2018): http://europepmc.org/abstract/med/29766579.
    10.1002/gps.4886
  84. Fumagalli GG; Basilico P; Arighi A; Bocchetta M; Dick KM; Cash DM; Harding S; et al. "Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales.". Alzheimer's research & therapy (2018): http://europepmc.org/abstract/med/29793546.
    10.1186/s13195-018-0376-9
  85. Baradaran-Heravi Y; Dillen L; Nguyen HP; Van Mossevelde S; Baets J; De Jonghe P; Engelborghs S; et al. "No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients.". Neurobiology of aging (2018): http://europepmc.org/abstract/med/29886022.
    10.1016/j.neurobiolaging.2018.05.005
  86. Schneider R; McKeever P; Kim T; Graff C; van Swieten JC; Karydas A; Boxer A; et al. "Downregulation of exosomal miR-204-5p and miR-632 as a biomarker for FTD: a GENFI study.". Journal of neurology, neurosurgery, and psychiatry (2018): http://europepmc.org/abstract/med/29434051.
    10.1136/jnnp-2017-317492
  87. Oliveira FPM; Moreira AP; de Mendonça A; Verdelho A; Xavier C; Barroca D; Rio J; et al. "Can 11C-PiB-PET Relative Delivery R1 or 11C-PiB-PET Perfusion Replace 18F-FDG-PET in the Assessment of Brain Neurodegeneration?". Journal of Alzheimer's disease : JAD (2018): http://europepmc.org/abstract/med/30056421.
    10.3233/jad-180274
  88. Sellami L; Bocchetta M; Masellis M; Cash DM; Dick KM; van Swieten J; Borroni B; et al. "Distinct Neuroanatomical Correlates of Neuropsychiatric Symptoms in the Three Main Forms of Genetic Frontotemporal Dementia in the GENFI Cohort.". Journal of Alzheimer's disease : JAD (2018): http://europepmc.org/abstract/med/30010122.
    10.3233/jad-180053
  89. Galimberti D; Fumagalli GG; Fenoglio C; Cioffi SMG; Arighi A; Serpente M; Borroni B; et al. "Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study.". Neurobiology of aging (2017): http://europepmc.org/abstract/med/29146050.
    10.1016/j.neurobiolaging.2017.10.016
  90. Gonçalves-Pereira M; Cardoso A; Verdelho A; Alves da Silva J; Caldas de Almeida M; Fernandes A; Raminhos C; et al. "The prevalence of dementia in a Portuguese community sample: a 10/66 Dementia Research Group study.". BMC geriatrics (2017): http://europepmc.org/abstract/med/29115922.
    10.1186/s12877-017-0647-5
  91. Cash DM; Bocchetta M; Thomas DL; Dick KM; van Swieten JC; Borroni B; Galimberti D; et al. "Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study.". Neurobiology of aging (2017): http://europepmc.org/abstract/med/29172163.
    10.1016/j.neurobiolaging.2017.10.008
  92. Skrobot OA; Black SE; Chen C; DeCarli C; Erkinjuntti T; Ford GA; Kalaria RN; et al. "Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study.". Alzheimer's & dementia : the journal of the Alzheimer's Association (2017): http://europepmc.org/abstract/med/29055812.
    10.1016/j.jalz.2017.09.007
  93. Macedo J; Carneiro E; Ferreira D; Verdelho A; Afonso LP; Maurício J; Silva SM; Arantes M. "Neuroimaging analysis of rare brain metastases from prostate cancer: PS171.". Porto biomedical journal (2017): http://europepmc.org/abstract/med/32258718.
    10.1016/j.pbj.2017.07.106
  94. Premi E; Grassi M; van Swieten J; Galimberti D; Graff C; Masellis M; Tartaglia C; et al. "Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study.". Brain : a journal of neurology (2017): http://europepmc.org/abstract/med/28460069.
    10.1093/brain/awx103
  95. Mutsaerts HJMM; Petr J; Thomas DL; De Vita E; Cash DM; van Osch MJP; Golay X; et al. "Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI).". Journal of magnetic resonance imaging : JMRI (2017): http://europepmc.org/abstract/med/28480617.
    10.1002/jmri.25751
  96. De Roeck A; Van den Bossche T; van der Zee J; Verheijen J; De Coster W; Van Dongen J; Dillen L; et al. "Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer's disease.". Acta neuropathologica (2017): http://europepmc.org/abstract/med/28447221.
    10.1007/s00401-017-1714-x
  97. Sudre CH; Bocchetta M; Cash D; Thomas DL; Woollacott I; Dick KM; van Swieten J; et al. "White matter hyperintensities are seen only in GRN mutation carriers in the GENFI cohort.". NeuroImage. Clinical (2017): http://europepmc.org/abstract/med/28529873.
    10.1016/j.nicl.2017.04.015
  98. Skrobot OA; O'Brien J; Black S; Chen C; DeCarli C; Erkinjuntti T; Ford GA; et al. "The Vascular Impairment of Cognition Classification Consensus Study.". Alzheimer's & dementia : the journal of the Alzheimer's Association (2016): http://europepmc.org/abstract/med/27960092.
    10.1016/j.jalz.2016.10.007
  99. Jokinen H; Melkas S; Madureira S; Verdelho A; Ferro JM; Fazekas F; Schmidt R; et al. "Cognitive reserve moderates long-term cognitive and functional outcome in cerebral small vessel disease.". Journal of neurology, neurosurgery, and psychiatry (2016): http://europepmc.org/abstract/med/27951523.
    10.1136/jnnp-2016-313914
  100. Madureira S; Verdelho A; Moleiro C; Santos C; Scheltens P; Gouw A; Ferro J. "White Matter Changes and Cognitive Decline in a Ten-Year Follow-Up Period: A Pilot Study on a Single-Center Cohort from the Leukoaraiosis and Disability Study.". Dementia and geriatric cognitive disorders (2016): http://europepmc.org/abstract/med/27380560.
    10.1159/000447121
  101. Gonçalves-Pereira, M; Cardoso, Ana; Verdelho, Ana; Silva, Joaquim Alves da; Caldas de Almeida, Manuel; Fernandes, Alexandra; Raminhos, Cátia; et al. "Implementação em Portugal de um estudo de prevalência da demência e da depressão geriátrica". (2016): http://www.scopus.com/inward/record.url?scp=84964845030&partnerID=8YFLogxK.
    https://doi.org/10.1016/j.rpsp.2016.03.002
  102. Jokinen H; Gonçalves N; Vigário R; Lipsanen J; Fazekas F; Schmidt R; Barkhof F; et al. "Early-Stage White Matter Lesions Detected by Multispectral MRI Segmentation Predict Progressive Cognitive Decline.". Frontiers in neuroscience (2015): http://europepmc.org/abstract/med/26696814.
    10.3389/fnins.2015.00455
  103. Guerreiro C; Silva B; Crespo ÂC; Marques L; Costa S; Timóteo Â; Marcelino E; et al. "Decrease in APP and CP mRNA expression supports impairment of iron export in Alzheimer's disease patients.". (2015): http://europepmc.org/abstract/med/26209012.
    10.1016/j.bbadis.2015.07.017
  104. Frederiksen KS; Verdelho A; Madureira S; Bäzner H; O'Brien JT; Fazekas F; Scheltens P; et al. "Physical activity in the elderly is associated with improved executive function and processing speed: the LADIS Study.". (2015): http://europepmc.org/abstract/med/25363336.
    10.1002/gps.4220
  105. Pires, C.; Coelho, M.; Valadas, A.; Barroso, C.; Pimentel, J.; Martins, M.; Duyckaerts, C.; et al. "Phenotypic variability of familial and sporadic progranulin p.Gln257Profs*27 mutation". Journal of Alzheimer's Disease 37 2 (2013): 335-342. http://www.scopus.com/inward/record.url?eid=2-s2.0-84883760645&partnerID=MN8TOARS.
    10.3233/JAD-130146
  106. Silva, D.; Albers, U.; Santana, I.; Vicente, M.; Martins, I.P.; Verdelho, A.; Guerreiro, M.; De-Mendonça, A.. "Do MCI patients with vitamin B12 deficiency have distinctive cognitive deficits?". BMC Research Notes 6 1 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84883519459&partnerID=MN8TOARS.
    10.1186/1756-0500-6-357
  107. Crespo, A.C.; Silva, B.; Marques, L.; Marcelino, E.; Maruta, C.; Costa, S.; Timóteo, A.; et al. "Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation". Neurobiology of Aging (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84886805706&partnerID=MN8TOARS.
    10.1016/j.neurobiolaging.2013.10.078
  108. Verdelho, A.; Madureira, S.; Moleiro, C.; Ferro, J.M.; O'Brien, J.T.; Poggesi, A.; Pantoni, L.; et al. "Depressive symptoms predict cognitive decline and dementia in older people independently of cerebral white matter changes: The LADIS study". Journal of Neurology, Neurosurgery and Psychiatry 84 11 (2013): 1250-1254. http://www.scopus.com/inward/record.url?eid=2-s2.0-84885619727&partnerID=MN8TOARS.
    10.1136/jnnp-2012-304191
  109. Moleiro, C.; Madureira, S.; Verdelho, A.; Ferro, J.M.; Poggesi, A.; Chabriat, H.; Erkinjuntti, T.; et al. "Confirmatory factor analysis of the Neuropsychological Assessment Battery of the LADIS study: A longitudinal analysis". Journal of Clinical and Experimental Neuropsychology 35 3 (2013): 269-278. http://www.scopus.com/inward/record.url?eid=2-s2.0-84875885862&partnerID=MN8TOARS.
    10.1080/13803395.2013.770822
  110. Bárrios, H.; Verdelho, A.; Narciso, S.; Gonçalves-Pereira, M.; Logsdon, R.; De Mendonça, A.. "Quality of life in patients with cognitive impairment: Validation of the Quality of Life-Alzheimer's Disease scale in Portugal". International Psychogeriatrics 25 7 (2013): 1085-1096. http://www.scopus.com/inward/record.url?eid=2-s2.0-84885460551&partnerID=MN8TOARS.
    10.1017/S1041610213000379
  111. Jokinen, H.; Schmidt, R.; Ropele, S.; Fazekas, F.; Gouw, A.A.; Barkhof, F.; Scheltens, P.; et al. "Diffusion changes predict cognitive and functional outcome: The LADIS study". Annals of Neurology 73 5 (2013): 576-583. http://www.scopus.com/inward/record.url?eid=2-s2.0-84878276075&partnerID=MN8TOARS.
    10.1002/ana.23802
  112. Firbank MJ; Teodorczuk A; van der Flier WM; Gouw AA; Wallin A; Erkinjuntti T; Inzitari D; et al. "Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study.". (2012): http://europepmc.org/abstract/med/22626634.
    10.1192/bjp.bp.111.098897
  113. Rostrup E; Gouw AA; Vrenken H; van Straaten EC; Ropele S; Pantoni L; Inzitari D; et al. "The spatial distribution of age-related white matter changes as a function of vascular risk factors--results from the LADIS study.". (2012): http://europepmc.org/abstract/med/22305990.
    10.1016/j.neuroimage.2012.01.106
  114. Jokinen, H.; Lipsanen, J.; Schmidt, R.; Fazekas, F.; Gouw, A.A.; Van Der Flier, W.M.; Barkhof, F.; et al. "Brain atrophy accelerates cognitive decline in cerebral small vessel disease The LADIS study". Neurology 78 22 (2012): 1785-1792. http://www.scopus.com/inward/record.url?eid=2-s2.0-84863629974&partnerID=MN8TOARS.
    10.1212/WNL.0b013e3182583070
  115. Frederiksen, K.S.; Garde, E.; Skimminge, A.; Barkhof, F.; Scheltens, P.; Van Straaten, E.C.W.; Fazekas, F.; et al. "Corpus callosum tissue loss and development of motor and global cognitive impairment: The LADIS study". Dementia and Geriatric Cognitive Disorders 32 4 (2012): 279-286. http://www.scopus.com/inward/record.url?eid=2-s2.0-84855901878&partnerID=MN8TOARS.
    10.1159/000334949
  116. Schmidt, R.; Berghold, A.; Jokinen, H.; Gouw, A.A.; Van Der Flier, W.M.; Barkhof, F.; Scheltens, P.; et al. "White matter lesion progression in LADIS: Frequency, clinical effects, and sample size calculations". Stroke 43 10 (2012): 2643-2647. http://www.scopus.com/inward/record.url?eid=2-s2.0-84866743847&partnerID=MN8TOARS.
    10.1161/STROKEAHA.112.662593
  117. Jokinen, H.; Frederiksen, K.S.; Garde, E.; Skimminge, A.; Siebner, H.; Waldemar, G.; Ylikoski, R.; et al. "Callosal tissue loss parallels subtle decline in psychomotor speed. A longitudinal quantitative MRI study. The LADIS Study". Neuropsychologia 50 7 (2012): 1650-1655. http://www.scopus.com/inward/record.url?eid=2-s2.0-84861223234&partnerID=MN8TOARS.
    10.1016/j.neuropsychologia.2012.03.020
  118. Verdelho, A.; Madureira, S.; Ferro, J.M.; Baezner, H.; Blahak, C.; Poggesi, A.; Hennerici, M.; et al. "Physical activity prevents progression for cognitive impairment and vascular dementia: Results from the LADIS (Leukoaraiosis and Disability) study". Stroke 43 12 (2012): 3331-3335. http://www.scopus.com/inward/record.url?eid=2-s2.0-84870946741&partnerID=MN8TOARS.
    10.1161/STROKEAHA.112.661793
  119. Ryberg C; Rostrup E; Paulson OB; Barkhof F; Scheltens P; van Straaten EC; van der Flier WM; et al. "Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort.". (2011): http://europepmc.org/abstract/med/21621224.
    10.1016/j.jns.2011.05.002
  120. Jokinen, H.; Gouw, A.A.; Madureira, S.; Ylikoski, R.; Van Straaten, E.C.W.; Van Der Flier, W.M.; Barkhof, F.; et al. "Incident lacunes influence cognitive decline: The LADIS study". Neurology 76 22 (2011): 1872-1878. http://www.scopus.com/inward/record.url?eid=2-s2.0-79958079946&partnerID=MN8TOARS.
    10.1212/WNL.0b013e31821d752f
  121. Verdelho, A.; Madureira, S.; Moleiro, C.; Santos, C.O.; Ferro, J.M.; Erkinjuntti, T.; Poggesi, A.; et al. "Self-perceived memory complaints predict progression to Alzheimer disease. the LADIS study". Journal of Alzheimer's Disease 27 3 (2011): 491-498. http://www.scopus.com/inward/record.url?eid=2-s2.0-82555193360&partnerID=MN8TOARS.
    10.3233/JAD-2011-110494
  122. Madureira, S.; Verdelho, A.; Pantoni, L.; Scheltens, P.. "White matter changes: New perspectives on imaging, clinical aspects, and intervention". Journal of Aging Research 2011 (2011): http://www.scopus.com/inward/record.url?eid=2-s2.0-84869486660&partnerID=MN8TOARS.
    10.4061/2011/841913
  123. LADIS Study Group. "2001–2011: a decade of the LADIS (Leukoaraiosis And DISability) Study: what have we learned about white matter changes and small-vessel disease?". (2011): http://europepmc.org/abstract/med/22279631.
    10.1159/000334498
  124. Teodorczuk A; Firbank MJ; Pantoni L; Poggesi A; Erkinjuntti T; Wallin A; Wahlund LO; et al. "Relationship between baseline white-matter changes and development of late-life depressive symptoms: 3-year results from the LADIS study.". (2010): http://europepmc.org/abstract/med/19671212.
    10.1017/S0033291709990857
  125. Madureira, S.; Verdelho, A.; Moleiro, C.; Ferro, J.M.; Erkinjuntti, T.; Jokinen, H.; Pantoni, L.; et al. "Neuropsychological predictors of dementia in a three-year follow-up period: Data from the ladis study on behalf of the ladis study". Dementia and Geriatric Cognitive Disorders 29 4 (2010): 325-334. http://www.scopus.com/inward/record.url?eid=2-s2.0-77950597053&partnerID=MN8TOARS.
    10.1159/000278333
  126. Schmidt, R.; Ropele, S.; Ferro, J.; Madureira, S.; Verdelho, A.; Petrovic, K.; Gouw, A.; et al. "Diffusion-weighted imaging and cognition in the leukoariosis and disability in the elderly study". Stroke 41 5 (2010): http://www.scopus.com/inward/record.url?eid=2-s2.0-77951767934&partnerID=MN8TOARS.
    10.1161/STROKEAHA.109.576629
  127. Verdelho, Ana; Madureira, S.; Moleiro, Carla; Ferro, J. M.; Santos, C. O.; Erkinjuntti, T.; Pantoni, L.; et al. "White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study". Neurology 75 2 (2010): 160-167. http://hdl.handle.net/10071/6803.
    10.1212/WNL.0b013e3181e7ca05
  128. Benisty, S.; Gouw, A.A.; Porcher, R.; Madureira, S.; Hernandez, K.; Poggesi, A.; Van Der Flier, W.M.; et al. "Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: The LADIS study". Journal of Neurology, Neurosurgery and Psychiatry 80 5 (2009): 478-483. http://www.scopus.com/inward/record.url?eid=2-s2.0-65449180760&partnerID=MN8TOARS.
    10.1136/jnnp.2008.160440
  129. Jokinen, H.; Kalska, H.; Ylikoski, R.; Madureira, S.; Verdelho, A.; Gouw, A.; Scheltens, P.; et al. "MRI-defined subcortical ischemic vascular disease: Baseline clinical and neuropsychological findings". Cerebrovascular Diseases 27 4 (2009): 336-344. http://www.scopus.com/inward/record.url?eid=2-s2.0-59849105048&partnerID=MN8TOARS.
    10.1159/000202010
  130. Jokinen, H.; Kalska, H.; Ylikoski, R.; Madureira, S.; Verdelho, A.; Van Der Flier, W.M.; Scheltens, P.; et al. "Longitudinal cognitive decline in subcortical ischemic vascular disease -the ladis study". Cerebrovascular Diseases 27 4 (2009): 384-391. http://www.scopus.com/inward/record.url?eid=2-s2.0-61649123570&partnerID=MN8TOARS.
    10.1159/000207442
  131. Inzitari D; Pracucci G; Poggesi A; Carlucci G; Barkhof F; Chabriat H; Erkinjuntti T; et al. "Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort.". (2009): http://europepmc.org/abstract/med/19581317.
    10.1136/bmj.b2477
  132. Gouw AA; van der Flier WM; Pantoni L; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; et al. "On the etiology of incident brain lacunes: longitudinal observations from the LADIS study.". (2008): http://europepmc.org/abstract/med/18703801.
    10.1161/STROKEAHA.108.521807
  133. Ryberg C; Rostrup E; Sjöstrand K; Paulson OB; Barkhof F; Scheltens P; van Straaten EC; et al. "White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study.". (2008): http://europepmc.org/abstract/med/18556357.
    10.3174/ajnr.A1169
  134. Dyrby TB; Rostrup E; Baaré WF; van Straaten EC; Barkhof F; Vrenken H; Ropele S; et al. "Segmentation of age-related white matter changes in a clinical multi-center study.". (2008): http://europepmc.org/abstract/med/18394928.
    10.1016/j.neuroimage.2008.02.024
  135. Gouw AA; van der Flier WM; Fazekas F; van Straaten EC; Pantoni L; Poggesi A; Inzitari D; et al. "Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.". (2008): http://europepmc.org/abstract/med/18323505.
    10.1161/STROKEAHA.107.498535
  136. Baezner H; Blahak C; Poggesi A; Pantoni L; Inzitari D; Chabriat H; Erkinjuntti T; et al. "Association of gait and balance disorders with age-related white matter changes: the LADIS study.". (2008): http://europepmc.org/abstract/med/18347315.
    10.1212/01.wnl.0000305959.46197.e6
  137. Verdelho, A.; Ferro, J.M.; Melo, T.; Canhão, P.; Falcão, F.. "Headache in acute stroke. A prospective study in the first 8 days". Cephalalgia 28 4 (2008): 346-354. http://www.scopus.com/inward/record.url?eid=2-s2.0-40349087009&partnerID=MN8TOARS.
    10.1111/j.1468-2982.2007.01514.x
  138. Poggesi, A.; Pracucci, G.; Chabriat, H.; Erkinjuntti, T.; Fazekas, F.; Verdelho, A.; Hennerici, M.; et al. "Urinary complaints in nondisabled elderly people with age-related white matter changes: The Leukoaraiosis And DISability (LADIS) Study". Journal of the American Geriatrics Society 56 9 (2008): 1638-1643. http://www.scopus.com/inward/record.url?eid=2-s2.0-51249090942&partnerID=MN8TOARS.
    10.1111/j.1532-5415.2008.01832.x
  139. Miranda, B.; Madureira, S.; Verdelho, A.; Ferro, J.; Pantoni, L.; Salvadori, E.; Chabriat, H.; et al. "Self-perceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes". Journal of Neurology, Neurosurgery and Psychiatry 79 8 (2008): 869-873. http://www.scopus.com/inward/record.url?eid=2-s2.0-48249109903&partnerID=MN8TOARS.
    10.1136/jnnp.2007.131078
  140. Verdelho, A.; Ferro, J.M.. "Late onset depressive symptoms can be a marker of cerebral vascular pathology". Journal of Neurology, Neurosurgery and Psychiatry 79 9 (2008): http://www.scopus.com/inward/record.url?eid=2-s2.0-50449098866&partnerID=MN8TOARS.
    10.1136/jnnp.2007.142364
  141. Gouw AA; van der Flier WM; van Straaten EC; Pantoni L; Bastos-Leite AJ; Inzitari D; Erkinjuntti T; et al. "Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression.". (2008): http://europepmc.org/abstract/med/18216467.
    10.1159/000113863
  142. Girot, M.; Gauvrit, J.-Y.; Cordonnier, C.; Pruvo, J.-P.; Verdelho, A.; Leys, D.; Leclerc, X.. "Prognostic value of hyperintense vessel signals on fluid-attenuated inversion recovery sequences in acute cerebral ischemia". European Neurology 57 2 (2007): 75-79. http://www.scopus.com/inward/record.url?eid=2-s2.0-33846949738&partnerID=MN8TOARS.
    10.1159/000098055
  143. Verdelho, A.; Madureira, S.; Ferro, J.M.; Basile, A.-M.; Chabriat, H.; Erkinjuntti, T.; Fazekas, F.; et al. "Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study". Journal of Neurology, Neurosurgery and Psychiatry 78 12 (2007): 1325-1330. http://www.scopus.com/inward/record.url?eid=2-s2.0-36849030286&partnerID=MN8TOARS.
    10.1136/jnnp.2006.110361
  144. Madureira, S.; Verdelho, A.; Ferro, J.; Basile, A.-M.; Chabriat, H.; Erkinjuntti, T.; Fazekas, F.; et al. "Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly study (LADIS): Experience and baseline data". Neuroepidemiology 27 2 (2006): 101-116. http://www.scopus.com/inward/record.url?eid=2-s2.0-33748655000&partnerID=MN8TOARS.
    10.1159/000095381
  145. Van Der Flier, W.M.; Van Straaten, E.C.W.; Barkhof, F.; Verdelho, A.; Madureira, S.; Pantoni, L.; Inzitari, D.; et al. "Small vessel disease and general cognitive function in nondisabled elderly: The LADIS study". Stroke 36 10 (2005): 2116-2120. http://www.scopus.com/inward/record.url?eid=2-s2.0-26444525643&partnerID=MN8TOARS.
    10.1161/01.STR.0000179092.59909.42
  146. Firbank, M.J.; O'Brien, J.T.; Pakrasi, S.; Pantoni, L.; Simoni, M.; Erkinjuntti, T.; Wallin, A.; et al. "White matter hyperintensities and depression - Preliminary results from the LADIS study". International Journal of Geriatric Psychiatry 20 7 (2005): 674-679. http://www.scopus.com/inward/record.url?eid=2-s2.0-23644449403&partnerID=MN8TOARS.
    10.1002/gps.1342
  147. Verdelho A; Hénon H; Lebert F; Pasquier F; Leys D; Verdelho, A.; Hénon, H.; et al. "Depressive symptoms after stroke and relationship with dementia: A three-year follow-up study.". Neurology 62 6 (2004): 905-911. http://europepmc.org/abstract/med/15037691.
    10.1212/01.WNL.0000115107.66957.8C
  148. Girot, M.; Leclerc, X.; Gauvrit, J.-Y.; Verdelho, A.; Pruvo, J.-P.; Leys, D.. "Cerebral magnetic resonance imaging within 6 hours of stroke onset: Inter- and intra-observer reproducibility". Cerebrovascular Diseases 16 2 (2003): 122-127. http://www.scopus.com/inward/record.url?eid=2-s2.0-0038618753&partnerID=MN8TOARS.
    10.1159/000070591
  149. Ferro, J.M.; Caeiro, L.; Verdelho, A.. "Delirium in acute stroke". Current Opinion in Neurology 15 1 (2002): 51-55. http://www.scopus.com/inward/record.url?eid=2-s2.0-0036162260&partnerID=MN8TOARS.
    10.1097/00019052-200202000-00009
  150. Verdelho, A.; Ferro, J.M.; Palmeiro, A.; Antunes, C.. "Cerebral venous thrombosis and familiar prothrombin gene G20210A mutation | Trombosis venosa cerebral y mutación G20210A del gen de la protrombina familiar". Revista de Neurologia 33 4 (2001): 335-338. http://www.scopus.com/inward/record.url?eid=2-s2.0-0035899156&partnerID=MN8TOARS.
  151. Verdelho A; Ferro JM; Palmeiro A; Antunes C. "[Cerebral venous thrombosis and familial prothrombin gene G20210a mutation]". (2001): http://europepmc.org/abstract/med/11588727.
  152. Verdelho, A.. "Two myopathy cases | Dos casos de miopatia". Revista de Neurologia 28 11 (1999): 1059-1061. http://www.scopus.com/inward/record.url?eid=2-s2.0-0033149959&partnerID=MN8TOARS.
  153. Verdelho A; Pereira JG; Ferro JM. "[Multiple vertebro-basilar infarcts and cardio-embolism]". (1999): http://europepmc.org/abstract/med/10390764.
  154. Verdelho A; Bentes C; de Carvalho M. "[Two myopathy cases].". (1999): http://europepmc.org/abstract/med/10390774.
Pré-impressão
  1. Anjo SI; Rosado M; Baldeiras I; Gomes A; Pires D; Santa C; Pinto J; et al. "Unmasking Hidden Systemic Effects of Neurodegenerative Diseases: A Two-Pronged Approach to Biomarker Discovery". 2023. http://europepmc.org/abstract/PPR/PPR764250.
    10.1101/2023.11.23.568435
  2. Jokinen H; Koikkalainen J; Laakso HM; Melkas S; Nieminen T; Brander A; Korvenoja A; et al. "Automated quantification of small vessel disease brain changes on MRI predicts cognitive and functional decline". 2019. http://europepmc.org/abstract/PPR/PPR77484.
    10.1101/621888
Revisão de livro
  1. Gonçalves-Pereira, Manuel; Verdelho, Ana; Prina, Matthew; Marques, Maria João; Xavier, Miguel. "How Many People Live with Dementia in Portugal? A Discussion Paper of National Estimates". http://hdl.handle.net/10362/125033.
    https://doi.org/10.1159/000516503
Tese / Dissertação
  1. Mateus, Mariana Isabel Abreu da Silva, 1991-. "Performance characterization of dual-task in community dwelling elderly people and mild vascular cognitive impairment". Mestrado, 2019. http://hdl.handle.net/10451/39415.
  2. Martins, Teresa Isabel Guerreiro Antunes, 1991-. "Cefaleias após acidente vascular cerebral isquémico : estudo prospetivo por um período de 6 meses". Mestrado, 2016. http://hdl.handle.net/10451/29567.
  3. Verdelho, Ana Isabel Figueira, 1969-. "Clinical implications of cerebral age-related white matter cerebral changes". Doutoramento, 2013. http://hdl.handle.net/10451/8722.